ABSTRACT
Background and purpose: The ataxia-telangiectasia mutated (ATM) gene results in ataxia-telangiectasia (A-T) and it is closely associated with tumors. ATM is an important signal transducer that is involved in the repair of DNA double-strand break damage by phosphorylating numerous target proteins . This study was aimed to investigate the correlation between a single nucleotide polymorphism (SNP) in ATM gene (IVS62+60G>A) and the risk of non-small cell lung cancer(NSCLC) in a case-control study. Methods: From June 2004 to December 2005, a total of 264 patients with NSCLC were recruited, 264 healthy people as control. All of specimens were collected from Zhejiang Tumor Hospital. DNA was extracted from peripheral blood and then was used to determine. ATM genotype by Taqman SNP genotyping assays. Logistic regression model was employed to analyze the relationship between SNP and NSCLC risk. Results: The percentage of NSCLC patients in 86 patients with A/A genotype, 139 patients with A/G and 39 patients with G/G were 32.6% (86/264), 52.6% (139/264), 14.8% (39/264), respectively. The percentage in 68 healthy people with A/A genotype, 139 healthy people with NG and 55 healthy people with G/G were 26.0% (68/262), 53.0% (139/262) and 21.0% (55/262), respectively. The proportion of G/G genotype in 264 patients was obviously lower than that in the 264 healthy control (14.8% vs 21.2%, P<0.05). The people with G/G genotype had lower risk to NSCLC than there with A/A genotype (OR=0.561, 95% CI=0.334-0.942, P=0.029). Conclusion: The ATM SNP(IVS62+60G>A)was associated with the NSCLC risk, and homozygous G alleles may be a protective factor to NSCLC.
ABSTRACT
Background and purpose:Measurement of tumor markers in serum is widely used for the diagnosis of lung cancer, but the positive rates of single marker for diagnosis of lung cancer were not high. This study was to investigate the clinical value of combined measurement of serum CYFRA21-1,NSE,CEA,CA19-9,CA125 for the diagnosis of lung cancer. Methods:The levels of CYFRA21-1,NSE,CEA,CA19-9,CA125,SCC were assayed and compared between the lung cancer group(135 cases) and cancer-free control group(20 case) by electrochemiluminesence immunoassay.Results:The levels of CYFRA21-1,NSE,CEA,CA19-9,CA125 and SCC in the lung cancer group were (7?8) ng/ml,(30?29) ng/ml,(65?293) ng/ml,(110?379) U/ml,(122?412) U/ml and (2?7) ng/ml, respectively, which were higher than those in the control group. The levels of the six tumor markers were associated with pathology of lung cancer, the levels of CEA were (11?25)?10 ng/ml,(2?4) ?10 ng/ml,(2?3)?10 ng/ml in the adenocarcinoma , squamous cell carcinoma and small cell carcinoma cases respectively; the levels of CA125 were (21?48)?10 U/ml,(48?57) ?10 U/ml,(5?4)?10 U/ml in the adenocarcinoma ,squamous cell carcinoma and small cell carcinoma patients, respectively; the levels of CA199 were (17?44) ?10 U/ml,(5?12)?10 U/ml,(4?4) ?10 U/ml in the adenocarcinoma, squamous cell carcinoma and small cell carcinoma patients, respectively. The levels of CEA,CA125,CA19-9 in the adenocarcinoma were higher than those in the squamous cell carcinoma and small cell carcinoma, but there was no significance different(P